For the Inventor, By the Inventor

Enter assignee name

San Francisco, CA, United States of America

The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone

USPTO Granted Patents = 19

EPO Patents = 13

Forward Citations = 12

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

Sheng Ding (7 out of 53 patents)

Saiyong Zhu (2 out of 16 patents)

Kevin Edward Healy (2 out of 26 patents)

4. Bruce Conklin (2 out of 7 patents)

5. Katerina Akassoglou (2 out of 13 patents)

6. Nathaniel Huebsch (2 out of 2 patents)

7. Tamer M A Mohamed (2 out of 2 patents)

8. Deepak Srivastava (2 out of 7 patents)

9. Jae Kyu Ryu (2 out of 4 patents)

10. Warner C Greene (2 out of 15 patents)

11. Robert Schwarcz (2 out of 20 patents)

12. Paul J Muchowski (2 out of 9 patents)

13. Joseph M Muchowski (2 out of 4 patents)

14. Paolo Guidetti (2 out of 4 patents)

15. Ke Li (1 out of 33 patents)

19 patents: Sort by Forward Citations

1. 12104169 - Chemical reprogramming to generate neuronal cells (2024-10-01),

2. 12016934 - Animal model for SARS-CoV-2-spike induced coagulopathy (2024-06-25),

3. 11898167 - Reversible stencils for fabricating micro-tissues (2024-02-13),

4. 11702630 - In vitro methods of differentiating stem cells into neurons and neurons generated using the same (2023-07-18),

5. 11590110 - Compositions and methods for reactivating latent immunodeficiency virus using a GSK-3 inhibitor (2023-02-28),

6. 11573222 - Compositions and methods for in vitro assays of fibrin activity (2023-02-07),

7. 11541102 - Methods for inducing cell division of postmitotic cells (2023-01-03),

8. 11332716 - Methods and compositions for producing pancreatic beta cells (2022-05-17),

9. 11241455 - Methods of treating disease by metabolic control of T-cell differentiation (2022-02-08),

10. 11098309 - Compositions and methods for reactivating latent immunodeficiency virus (2021-08-24),

11. 10851344 - Reversible stencils for fabricating micro-tissues (2020-12-01),

12. 10669596 - Methods for inducing cell division of postmitotic cells (2020-06-02),

13. 10611741 - Substituted benzoxazine and related compounds (2020-04-07),

14. 10363256 - Methods for treatment of retinal disease by photoreceptor gene expression modulation (2019-07-30),

15. 10144915 - Reprogramming fibroblasts into cardiomyocytes (2018-12-04),

The J. David Gladstone Institutes is a testamentary trust established under the Will of J. David Gladstone. It is an independent research organization that focuses on basic science discoveries to improve human health. The Institutes comprise three centers: Gladstone Institute of Cardiovascular Disease, Gladstone Institute of Virology and Immunology, and Gladstone Institute of Neurological Disease. Through innovative research, they aim to unlock the causes, treatment, and prevention of various diseases such as cardiovascular diseases, viral infections, and neurological disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

19 Patents

#237 in San Francisco, CA

#3,961 in California

#16,579 in US

#31,656 in the World

San Francisco, CA, United States of America

The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone

Forward Citations = 12

46 inventors:

Sheng Ding (7 out of 53 patents)

Saiyong Zhu (2 out of 16 patents)

Kevin Edward Healy (2 out of 26 patents)

4. Bruce Conklin (2 out of 7 patents)

5. Katerina Akassoglou (2 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…